A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT01168310. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Pharmacodynamic Response of Fluticasone Propionate in Fixed-Dose Combination With Formoterol Fumarate in Subjects With COPD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, multi-dose, parallel group trial which will assess the pharmacodynamic response of fluticasone propionate and formoterol fumarate in subjects with COPD.
Study identification
- NCT ID
- NCT01168310
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 468 participants
Conditions and interventions
Conditions
Interventions
- Fluticasone Propionate/Formoterol Fumarate Drug
- Formoterol Fumarate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Days and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2010
- Primary completion
- Jul 31, 2010
- Completion
- Sep 30, 2011
- Last update posted
- May 26, 2013
2010 – 2011
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Phoenix | Arizona | — | — |
| Investigative Site | Fullerton | California | — | — |
| Investigative Site | San Diego | California | — | — |
| Investigative Site | Clearwater | Florida | — | — |
| Investigative Site | DeLand | Florida | — | — |
| Investigative Site | Tamarac | Florida | — | — |
| Investigative Site | Lawrenceville | Georgia | — | — |
| Investigative Site | Coeur d'Alene | Idaho | — | — |
| Investigative Site | Madisonville | Kentucky | — | — |
| Investigative Site | Sunset | Louisiana | — | — |
| Investigative Site | St Louis | Missouri | — | — |
| Investigative Site | Charlotte | North Carolina | — | — |
| Investigative Site | Raleigh | North Carolina | — | — |
| Investigative site | Sylvania | Ohio | — | — |
| Investigative Site | Medford | Oregon | — | — |
| Investigative Site | Easley | South Carolina | — | — |
| Investigative Site | Gaffney | South Carolina | — | — |
| Investigative Site | Greenville | South Carolina | — | — |
| Investigative Site | Greer | South Carolina | — | — |
| Investigative Site | Spartanburg | South Carolina | — | — |
| Invesigative Site | Union | South Carolina | — | — |
| Investigative Site | San Antonio | Texas | — | — |
| Investigative Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01168310, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2013 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01168310 live on ClinicalTrials.gov.